CANCER OF MULTIPLE TYPES, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Abnormality of metabolism/homeostasis
|
phenotype |
|
Finding
|
171
|
5
|
0.100 |
None |
|
0 |
|
|
|
Fibrofolliculoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
10
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
543
|
432
|
0.100 |
None |
|
0 |
2
|
|
|
Neoplasm of uncertain or unknown behavior of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
41
|
|
0.300 |
None |
|
0 |
|
|
|
Serum alkaline phosphatase raised
|
phenotype |
|
Finding
|
67
|
6
|
0.100 |
None |
|
0 |
|
|
|
Somatic mutation
|
phenotype |
|
Cell or Molecular Dysfunction
|
151
|
|
0.100 |
None |
|
0 |
|
|
|
Carcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
557
|
91
|
0.100 |
None |
|
0 |
1
|
|
|
Diffuse Intrinsic Pontine Glioma
|
disease |
|
Neoplastic Process
|
87
|
9
|
0.100 |
None |
|
0 |
1
|
|
|
Weight decreased
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
271
|
3
|
0.100 |
None |
|
0 |
|
|
|
Tumors of Adrenal Cortex
|
group |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
74
|
5
|
0.100 |
None |
|
0 |
|
|
|
Polyp of large intestine
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
99
|
32
|
0.100 |
None |
|
0 |
1
|
|
|
Abnormality of the fallopian tube
|
phenotype |
|
Anatomical Abnormality
|
22
|
|
0.100 |
None |
|
0 |
|
|
|
Breast adenocarcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
219
|
7
|
0.300 |
None |
|
0 |
|
|
|
Type 1 Papillary Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
4
|
14
|
0.100 |
None |
|
0 |
2
|
|
|
Osteolysis
|
phenotype |
Musculoskeletal Diseases
|
Pathologic Function
|
62
|
|
0.100 |
None |
|
0 |
|
|
|
Parathyroid Adenoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
133
|
12
|
0.100 |
None |
|
0 |
1
|
|
|
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
342
|
108
|
0.300 |
None |
|
0 |
|
|
|
Inflammation of large intestine
|
phenotype |
Digestive System Diseases
|
Disease or Syndrome
|
12
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Refractory Cytopenia of Childhood
|
disease |
|
Neoplastic Process
|
264
|
3
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Carcinoma, Lobular
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
66
|
1
|
0.010 |
None |
< 0.001 |
1 |
1
|
2005 |
2005 |
Acute monocytic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
633
|
22
|
0.010 |
None |
< 0.001 |
1 |
|
2009 |
2009 |
HER2 gene amplification
|
disease |
|
Disease or Syndrome
|
170
|
14
|
0.010 |
None |
< 0.001 |
1 |
|
2006 |
2006 |
Li-Fraumeni-Like Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
10
|
8
|
0.010 |
None |
< 0.001 |
1 |
|
2001 |
2001 |
Esophageal carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1287
|
272
|
0.010 |
None |
< 0.001 |
1 |
2
|
2012 |
2012 |